12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          α-Synuclein (α-syn), a small protein that has the intrinsic propensity to aggregate, is implicated in several neurodegenerative diseases including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA), which are collectively known as synucleinopathies. Genetic, pathological, biochemical, and animal modeling studies provided compelling evidence that α-syn aggregation plays a key role in the pathogenesis of PD and related synucleinopathies. It is therefore of utmost importance to develop reliable tools that can detect the aggregated forms of α-syn. We describe here the generation and characterization of six novel conformation-specific monoclonal antibodies that recognize specifically α-syn aggregates but not the soluble, monomeric form of the protein. The antibodies described herein did not recognize monomers or fibrils generated from other amyloidogenic proteins including β-syn, γ-syn, β-amyloid, tau protein, islet amyloid polypeptide and ABri. Interestingly, the antibodies did not react to overlapping linear peptides spanning the entire sequence of α-syn, confirming further that they only detect α-syn aggregates. In immunohistochemical studies, the new conformation-specific monoclonal antibodies showed underappreciated small micro-aggregates and very thin neurites in PD and DLB cases that were not observed with generic pan antibodies that recognize linear epitope. Furthermore, employing one of our conformation-specific antibodies in a sandwich based ELISA, we observed an increase in levels of α-syn oligomers in brain lysates from DLB compared to Alzheimer's disease and control samples. Therefore, the conformation-specific antibodies portrayed herein represent useful tools for research, biomarkers development, diagnosis and even immunotherapy for PD and related pathologies.

          Related collections

          Author and article information

          Journal
          Neurobiol. Dis.
          Neurobiology of disease
          1095-953X
          0969-9961
          Jul 2015
          : 79
          Affiliations
          [1 ] Department of Biochemistry, College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates; Neural Plasticity and Repair Unit, Department of Experimental Medical Sciences, Wallenberg Neuroscience Center, BMC A10, Lund University, Lund, Sweden.
          [2 ] Department of Biochemistry, College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates; Department of Anatomy and Neurosciences, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
          [3 ] Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.
          [4 ] Department of Biochemistry, College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates.
          [5 ] Department of Anatomy and Neurosciences, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
          [6 ] Discipline of Pathology, Charles Perkin Centre, University of Sydney, Sydney, Australia.
          [7 ] Department of Clinical Neurology, University of Oxford, Oxford, UK.
          [8 ] Department of Human Physiology, School of Medicine, Flinders University, Australia.
          [9 ] Department of Research for Parkinson's Disease, Juntendo University Graduate School of Medicine, Japan; Department of Neurology, Juntendo University Graduate School of Medicine, Japan.
          [10 ] Department of Neurology, Juntendo University Graduate School of Medicine, Japan.
          [11 ] Neuroscience Research Institute, Department of Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea.
          [12 ] Clinical and Cognitive Neuroscience Research Group, University of Manchester, Salford Royal Foundation NHS Trust, Salford M6 8HD, UK.
          [13 ] Department of Research for Parkinson's Disease, Juntendo University Graduate School of Medicine, Japan.
          [14 ] Faculty of Medicine, University of New South Wales and Neuroscience Research Australia, Sydney, Australia.
          [15 ] Neural Plasticity and Repair Unit, Department of Experimental Medical Sciences, Wallenberg Neuroscience Center, BMC A10, Lund University, Lund, Sweden.
          [16 ] Department of Biochemistry, College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates; College of Science, Engineering and Technology, HBKU, Education City, Qatar Foundation, Doha, Qatar. Electronic address: oelagnaf@qf.org.qa.
          Article
          S0969-9961(15)00156-4
          10.1016/j.nbd.2015.04.009
          25937088
          d328675e-9f22-46b1-b6ba-93cc2c25a0ca
          Copyright © 2015 Elsevier Inc. All rights reserved.
          History

          Conformation-specific monoclonal antibodies,Dementia with Lewy bodies,Parkinson’s disease,α-Synuclein

          Comments

          Comment on this article